DIGITAL ARCHIPELAGO

‘Análisis y evaluación de políticas de fomento de la competencia en el mercado farmacéutico español’

Biomedicine and Health

Biomedical Research

2004

The overall aim of the research is to produce, systematise and disseminate (nationally and internationally) rigorous assessments of the benefits and drawbacks of (applied and prospective) competition policies in the Spanish pharmaceuticals market.

DIRECTOR

Jaume Puig Junoy

RESEARCH TEAM

Anna Merino Castelló, Henry George Grabowski, Jaume Font Planells, Joan Costa Font, Joan Ramón Borrell.

COLLABORATING INSTITUTIONS

Universitat Pompeu Fabra

DESCRIPTION

This study will be conducted from the perspective of economic theory and applied economy, with the aim of providing evaluative tools for use in decision-making on industry regulation and the public financing of drugs (evidence-based pharmaceutical policy). Three areas will be subject to scrutiny: 1) competition policies in the generics market (when patents have expired); 2) competition policies in innovation product markets (protected by patent) and, finally, 3) competition policies in pharmaceutical retailing (pharmacies).